ResearcherIbaraki Prefectural Central HospitalActive in the last 2 years

Kenji Amagai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0149-8328; OpenAlex author ID A5016038702. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

A case of hemobilia caused by a pseudoaneurysm resulting in obstructive cholangitis in a patient who underwent plastic stent placement for pancreatic cancer (w… Last author DOI 10.1002/deo2.70130 ↗
Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: stu… Co-author DOI 10.1186/s12885-024-11973-9 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yusuke Seyama · 1 shared paper, 2026 · strength 0.29
- Paper A case of hemobilia caused by a pseudoaneurysm resulting in obstructive cholangitis in a patient who underwent plastic … DOI 10.1002/deo2.70130 ↗
Atsushi Satō · 1 shared paper, 2024 · strength 0.21
- Paper Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patie… DOI 10.1186/s12885-024-11973-9 ↗
Hiroo Imai · 1 shared paper, 2024 · strength 0.21
- Paper Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patie… DOI 10.1186/s12885-024-11973-9 ↗
Chikashi Ishioka · 1 shared paper, 2024 · strength 0.21
- Paper Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patie… DOI 10.1186/s12885-024-11973-9 ↗
Hiroyuki Shibata · 1 shared paper, 2024 · strength 0.21
- Paper Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patie… DOI 10.1186/s12885-024-11973-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.